Skip to main content
. 2020 Jun 17;144:110005. doi: 10.1016/j.mehy.2020.110005

Fig. 1.

Fig. 1

Pirfenidone could inhibit apoptosis, downregulate ACE receptors expression, decrease inflammation by several mechanisms and ameliorate oxidative stress and hence protect pneumocytes and other cells from the COVID-19 invasion and cytokine storm simultaneously.